Knockdown of WISP1/DKK1 restrains phenotypic plasticity in esophageal squamous cell carcinoma by suppressing epithelial–mesenchymal transition and stemness
Objective Wnt-induced signaling protein 1 (WISP1) and Dickkopf-1 (DKK1) are highly expressed in esophageal squamous cell carcinoma (ESCC), but no direct connection was identified between them. Phenotypic plasticity is a hallmark of ESCC. This research intended to identify the association between WIS...
Saved in:
Published in | Clinical & translational oncology Vol. 27; no. 2; pp. 580 - 592 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Cham
Springer International Publishing
01.02.2025
|
Subjects | |
Online Access | Get full text |
ISSN | 1699-3055 1699-3055 |
DOI | 10.1007/s12094-024-03639-6 |
Cover
Abstract | Objective
Wnt-induced signaling protein 1 (WISP1) and Dickkopf-1 (DKK1) are highly expressed in esophageal squamous cell carcinoma (ESCC), but no direct connection was identified between them. Phenotypic plasticity is a hallmark of ESCC. This research intended to identify the association between WISP1 and DKK1 and their roles in the phenotypic plasticity of ESCC.
Methods
Genes differentially expressed in esophageal carcinoma were analyzed in the GEO database, followed by analyses of GO and KEGG enrichment to screen the hub gene. WISP1 expression and DKK1 secretion was assessed in ESCC tissues and cells. The tumor xenograft and in vivo metastasis models were established by injecting ESCC cells into nude mice. Functional deficiency and rescue experiments were conducted, followed by assays for cell proliferation, migration/invasion, stemness, epithelial–mesenchymal transition (EMT), and apoptosis, as well as tumor volume, weight, proliferation, stemness, and lung metastasis. The binding relationship and co-expression of WISP1 and DKK1 were determined.
Results
WISP1 and DKK1 were upregulated in ESCC cells and tissues, and WISP1 was enriched in the cell stemness and Wnt pathways. WISP1 knockdown subdued proliferation, migration/invasion, EMT activity, and stemness but enhanced apoptosis in ESCC cells. WISP1 knockdown restrained ESCC growth, proliferation, stemness, and metastasis in vivo. WISP1 bound to DKK1 in ESCC. DKK1 overexpression abolished the repressive impacts of WISP1 knockdown on the malignant behaviors of ESCC cells in vitro and of ESCC tumor in vivo.
Conclusion
Knockdown of WISP1/DKK1 restrains the phenotypic plasticity in esophageal squamous cell carcinoma by suppressing epithelial–mesenchymal transition and stemness. |
---|---|
AbstractList | Wnt-induced signaling protein 1 (WISP1) and Dickkopf-1 (DKK1) are highly expressed in esophageal squamous cell carcinoma (ESCC), but no direct connection was identified between them. Phenotypic plasticity is a hallmark of ESCC. This research intended to identify the association between WISP1 and DKK1 and their roles in the phenotypic plasticity of ESCC.
Genes differentially expressed in esophageal carcinoma were analyzed in the GEO database, followed by analyses of GO and KEGG enrichment to screen the hub gene. WISP1 expression and DKK1 secretion was assessed in ESCC tissues and cells. The tumor xenograft and in vivo metastasis models were established by injecting ESCC cells into nude mice. Functional deficiency and rescue experiments were conducted, followed by assays for cell proliferation, migration/invasion, stemness, epithelial-mesenchymal transition (EMT), and apoptosis, as well as tumor volume, weight, proliferation, stemness, and lung metastasis. The binding relationship and co-expression of WISP1 and DKK1 were determined.
WISP1 and DKK1 were upregulated in ESCC cells and tissues, and WISP1 was enriched in the cell stemness and Wnt pathways. WISP1 knockdown subdued proliferation, migration/invasion, EMT activity, and stemness but enhanced apoptosis in ESCC cells. WISP1 knockdown restrained ESCC growth, proliferation, stemness, and metastasis in vivo. WISP1 bound to DKK1 in ESCC. DKK1 overexpression abolished the repressive impacts of WISP1 knockdown on the malignant behaviors of ESCC cells in vitro and of ESCC tumor in vivo.
Knockdown of WISP1/DKK1 restrains the phenotypic plasticity in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition and stemness. Wnt-induced signaling protein 1 (WISP1) and Dickkopf-1 (DKK1) are highly expressed in esophageal squamous cell carcinoma (ESCC), but no direct connection was identified between them. Phenotypic plasticity is a hallmark of ESCC. This research intended to identify the association between WISP1 and DKK1 and their roles in the phenotypic plasticity of ESCC.OBJECTIVEWnt-induced signaling protein 1 (WISP1) and Dickkopf-1 (DKK1) are highly expressed in esophageal squamous cell carcinoma (ESCC), but no direct connection was identified between them. Phenotypic plasticity is a hallmark of ESCC. This research intended to identify the association between WISP1 and DKK1 and their roles in the phenotypic plasticity of ESCC.Genes differentially expressed in esophageal carcinoma were analyzed in the GEO database, followed by analyses of GO and KEGG enrichment to screen the hub gene. WISP1 expression and DKK1 secretion was assessed in ESCC tissues and cells. The tumor xenograft and in vivo metastasis models were established by injecting ESCC cells into nude mice. Functional deficiency and rescue experiments were conducted, followed by assays for cell proliferation, migration/invasion, stemness, epithelial-mesenchymal transition (EMT), and apoptosis, as well as tumor volume, weight, proliferation, stemness, and lung metastasis. The binding relationship and co-expression of WISP1 and DKK1 were determined.METHODSGenes differentially expressed in esophageal carcinoma were analyzed in the GEO database, followed by analyses of GO and KEGG enrichment to screen the hub gene. WISP1 expression and DKK1 secretion was assessed in ESCC tissues and cells. The tumor xenograft and in vivo metastasis models were established by injecting ESCC cells into nude mice. Functional deficiency and rescue experiments were conducted, followed by assays for cell proliferation, migration/invasion, stemness, epithelial-mesenchymal transition (EMT), and apoptosis, as well as tumor volume, weight, proliferation, stemness, and lung metastasis. The binding relationship and co-expression of WISP1 and DKK1 were determined.WISP1 and DKK1 were upregulated in ESCC cells and tissues, and WISP1 was enriched in the cell stemness and Wnt pathways. WISP1 knockdown subdued proliferation, migration/invasion, EMT activity, and stemness but enhanced apoptosis in ESCC cells. WISP1 knockdown restrained ESCC growth, proliferation, stemness, and metastasis in vivo. WISP1 bound to DKK1 in ESCC. DKK1 overexpression abolished the repressive impacts of WISP1 knockdown on the malignant behaviors of ESCC cells in vitro and of ESCC tumor in vivo.RESULTSWISP1 and DKK1 were upregulated in ESCC cells and tissues, and WISP1 was enriched in the cell stemness and Wnt pathways. WISP1 knockdown subdued proliferation, migration/invasion, EMT activity, and stemness but enhanced apoptosis in ESCC cells. WISP1 knockdown restrained ESCC growth, proliferation, stemness, and metastasis in vivo. WISP1 bound to DKK1 in ESCC. DKK1 overexpression abolished the repressive impacts of WISP1 knockdown on the malignant behaviors of ESCC cells in vitro and of ESCC tumor in vivo.Knockdown of WISP1/DKK1 restrains the phenotypic plasticity in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition and stemness.CONCLUSIONKnockdown of WISP1/DKK1 restrains the phenotypic plasticity in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition and stemness. Objective Wnt-induced signaling protein 1 (WISP1) and Dickkopf-1 (DKK1) are highly expressed in esophageal squamous cell carcinoma (ESCC), but no direct connection was identified between them. Phenotypic plasticity is a hallmark of ESCC. This research intended to identify the association between WISP1 and DKK1 and their roles in the phenotypic plasticity of ESCC. Methods Genes differentially expressed in esophageal carcinoma were analyzed in the GEO database, followed by analyses of GO and KEGG enrichment to screen the hub gene. WISP1 expression and DKK1 secretion was assessed in ESCC tissues and cells. The tumor xenograft and in vivo metastasis models were established by injecting ESCC cells into nude mice. Functional deficiency and rescue experiments were conducted, followed by assays for cell proliferation, migration/invasion, stemness, epithelial–mesenchymal transition (EMT), and apoptosis, as well as tumor volume, weight, proliferation, stemness, and lung metastasis. The binding relationship and co-expression of WISP1 and DKK1 were determined. Results WISP1 and DKK1 were upregulated in ESCC cells and tissues, and WISP1 was enriched in the cell stemness and Wnt pathways. WISP1 knockdown subdued proliferation, migration/invasion, EMT activity, and stemness but enhanced apoptosis in ESCC cells. WISP1 knockdown restrained ESCC growth, proliferation, stemness, and metastasis in vivo. WISP1 bound to DKK1 in ESCC. DKK1 overexpression abolished the repressive impacts of WISP1 knockdown on the malignant behaviors of ESCC cells in vitro and of ESCC tumor in vivo. Conclusion Knockdown of WISP1/DKK1 restrains the phenotypic plasticity in esophageal squamous cell carcinoma by suppressing epithelial–mesenchymal transition and stemness. |
Author | Su, X. Lu, Z. Shi, J. Fu, C. Liu, F. |
Author_xml | – sequence: 1 givenname: C. surname: Fu fullname: Fu, C. organization: Department of Oncology, School of Medicine, Zhongda Hospital, Southeast University – sequence: 2 givenname: Z. surname: Lu fullname: Lu, Z. organization: Department of Oncology, School of Medicine, Zhongda Hospital, Southeast University – sequence: 3 givenname: J. surname: Shi fullname: Shi, J. organization: Department of Ultrasound, Zhongda Hospital, Medical School, Southeast University – sequence: 4 givenname: F. surname: Liu fullname: Liu, F. organization: Department of Medical Oncology, Luhe People’s Hospital of Nanjing – sequence: 5 givenname: X. orcidid: 0000-0001-6486-3110 surname: Su fullname: Su, X. email: suxiangyu1982@163.com organization: Department of Oncology, School of Medicine, Zhongda Hospital, Southeast University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39093516$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc1u1DAUhS1URH_gBVggL9mE2vHYiZeolFJNJZBaqUvLcW5mXBI79U2Esus7dN2X40nwMAWxYnHlu_jOuTo-x-QgxACEvOXsA2esOkVeMr0qWJlHKKEL9YIccaV1IZiUB__sh-QY8Y7lTXH-ihwKzbSQXB2Rp3WI7nsbfwQaO3p7ef2Nn35arzlNgFOyPiAdtxDitIze0bG3OHnnp4X6QAHjuLUbsD3F-9kOcUbqoO-ps8n5EAdLm4XiPI7ZDH3YUBj9tIXe2_7nw-MACMFtlyHr86mAfvIxUBtaihMMIWtek5ed7RHePL8n5Obz-c3Zl-Lq68Xl2cerwpW6ngou69Y5ZSuohJSwcqyGUrVKSN0p21SicxK6Soq6tI1mK7BCV6uy49I2rHTihLzf244p3s85uBk87pLYADmUEazOxqrUPKPvntG5GaA1Y_KDTYv586MZKPeASxExQfcX4czsajP72kyuzfyuzexEYi_CDIcNJHMX5xRy5P-pfgGuvZ8L |
Cites_doi | 10.1007/978-1-0716-0377-2_1 10.1177/1535370221992703 10.18632/aging.203430 10.1016/j.envint.2021.106880 10.1007/s10735-011-9347-1 10.1093/jrr/rrw030 10.1038/s41467-022-29018-9 10.1016/j.apsb.2021.03.009 10.1177/0960327113510537 10.1158/2159-8290.CD-21-1059 10.18632/oncotarget.4529 10.2147/CMAR.S275172 10.1007/s12195-019-00602-2 10.1074/jbc.RA118.006122 10.1016/j.pharmthera.2020.107692 10.3390/ijms23031353 10.21037/jgo-2019-gi-08 10.1158/2159-8290.CD-21-0282 10.2174/1567202617666200327125257 10.1016/bs.acr.2019.05.004 10.1080/21655979.2022.2068738 10.1111/j.1442-2050.2011.01279.x 10.15761/JTS.1000112 10.3892/or.2022.8333 10.18632/oncotarget.3358 10.1016/j.biocel.2008.07.025 10.30802/AALAS-JAALAS-18-000005 10.1016/j.stem.2018.11.011 10.1016/j.ydbio.2017.07.025 10.1111/bph.13894 10.1038/s41388-021-01860-z 10.3390/cancers13051009 10.2174/138945008784911750 10.1111/jcmm.12862 10.2174/1567202611666140912115107 10.1007/s10555-023-10087-1 10.1016/j.biocel.2015.03.007 |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO) 2024 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2024. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO). |
Copyright_xml | – notice: The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO) 2024 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2024. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO). |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1007/s12094-024-03639-6 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1699-3055 |
EndPage | 592 |
ExternalDocumentID | 39093516 10_1007_s12094_024_03639_6 |
Genre | Journal Article |
GrantInformation_xml | – fundername: Research project of Jiangsu Provincial Health Commission grantid: No.M2022073 – fundername: hinese and Western Medicine Collaborative Medical Research Project, Zhongda Hospital, Southeast University grantid: No.2023zxyxt11 |
GroupedDBID | -05 -0E -5E -5G -BR -EM -S~ -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 1N0 203 29B 29~ 2B. 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 4.4 406 408 40D 40E 53G 5GY 5VR 5VS 67Z 6NX 8TC 8UJ 92I 92M 93N 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABDZT ABECU ABFTV ABHQN ABIPD ABJNI ABJOX ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABULA ABWNU ABXPI ACAOD ACDTI ACGFS ACHSB ACHVE ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACZOJ ADHIR ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ AXYYD B-. BA0 BDATZ BGNMA BSONS CAG CCEZO CHBEP CIEJG COF CS3 CSCUP DDRTE DNIVK DPUIP EBLON EBS EIOEI EJD EN4 ESBYG F5P FA0 FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 H13 HF~ HG5 HG6 HMJXF HRMNR HZ~ IJ- IKXTQ IMOTQ IWAJR IXD IZQ I~X I~Z J-C J0Z JBSCW JUIAU JZLTJ KOV KPH LLZTM M4Y MA- NPVJJ NQJWS NU0 O9- O93 O9I O9J OAM P2P P9S PF0 PT4 Q-- Q-4 QOR QOS R89 R9I ROL RPX RSV RT5 S16 S1Z S27 S37 S3B SAP SDH SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZ9 SZN T13 T8U TCJ TSG TSK TSV TT1 TUC U1F U1G U2A U5O U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W48 WK8 YLTOR Z45 Z7D Z7U Z82 Z87 ZMTXR ZOVNA ~A9 ~N8 AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC AEZWR AFDZB AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION CGR CUY CVF ECM EIF NPM 7X8 ABRTQ |
ID | FETCH-LOGICAL-c298t-158dcc6a7e7355e4c08e26d6359f6ab73fc5ef75382ab904ea39742f15ab02c3 |
IEDL.DBID | AGYKE |
ISSN | 1699-3055 |
IngestDate | Fri Sep 05 07:56:17 EDT 2025 Fri Apr 25 03:25:47 EDT 2025 Tue Jul 01 03:55:56 EDT 2025 Fri Feb 21 02:36:38 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Wnt1 inducible signaling pathway protein 1 Phenotypic plasticity Esophageal squamous cell carcinoma Dickkopf-1 Metastasis |
Language | English |
License | 2024. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c298t-158dcc6a7e7355e4c08e26d6359f6ab73fc5ef75382ab904ea39742f15ab02c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-6486-3110 |
PMID | 39093516 |
PQID | 3087356291 |
PQPubID | 23479 |
PageCount | 13 |
ParticipantIDs | proquest_miscellaneous_3087356291 pubmed_primary_39093516 crossref_primary_10_1007_s12094_024_03639_6 springer_journals_10_1007_s12094_024_03639_6 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2025-02-01 |
PublicationDateYYYYMMDD | 2025-02-01 |
PublicationDate_xml | – month: 02 year: 2025 text: 2025-02-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Cham |
PublicationPlace_xml | – name: Cham – name: Italy |
PublicationTitle | Clinical & translational oncology |
PublicationTitleAbbrev | Clin Transl Oncol |
PublicationTitleAlternate | Clin Transl Oncol |
PublicationYear | 2025 |
Publisher | Springer International Publishing |
Publisher_xml | – name: Springer International Publishing |
References | H Li (3639_CR7) 2022 M Katoh (3639_CR21) 2008; 9 K Fousek (3639_CR28) 2021; 219 H Begenik (3639_CR40) 2014; 33 M Wu (3639_CR20) 2022; 13 C O'Brien-Ball (3639_CR29) 2017; 430 D Song (3639_CR35) 2021; 246 DB Burkhardt (3639_CR27) 2022; 12 MH Kagey (3639_CR38) 2017; 174 D Hanahan (3639_CR8) 2022; 12 J Tímár (3639_CR37) 2023; 42 G Sun (3639_CR24) 2022; 237 SX Han (3639_CR17) 2015; 6 G Zhu (3639_CR39) 2021; 13 AK Lam (3639_CR2) 2020; 2129 Y Wang (3639_CR23) 2012; 25 VJ Grille (3639_CR5) 2021; 12 H Jiang (3639_CR16) 2022; 13 W Deng (3639_CR34) 2020; 13 S Li (3639_CR43) 2011; 42 Y Zhao (3639_CR1) 2021; 11 MA Creamer-Hente (3639_CR22) 2018; 57 A Barzegar Behrooz (3639_CR30) 2022; 23 I Gurbuz (3639_CR32) 2015; 62 K Maiese (3639_CR9) 2016; 1 L Qiu (3639_CR6) 2022; 546 H Kimura (3639_CR19) 2021; 40 CC Chen (3639_CR10) 2009; 41 Q Song (3639_CR41) 2021; 13 PB Gupta (3639_CR26) 2019; 24 H Zhang (3639_CR14) 2015; 6 Y Nagai (3639_CR33) 2011; 31 M Tarazi (3639_CR3) 2021; 13 K Maiese (3639_CR11) 2020; 17 C Yang (3639_CR15) 2021; 49 W Deng (3639_CR13) 2019; 294 K Maiese (3639_CR31) 2014; 11 L Yao (3639_CR44) 2016; 20 Z Lu (3639_CR42) 2017; 10 T Lipenga (3639_CR4) 2021; 157 O Lyros (3639_CR18) 2019; 9 ZW Reichenbach (3639_CR25) 2019; 144 F Fang (3639_CR12) 2022; 13 H Zhang (3639_CR36) 2016; 57 |
References_xml | – volume: 49 start-page: 300060521101993 issue: 5 year: 2021 ident: 3639_CR15 publication-title: J Int Med Res – volume: 2129 start-page: 1 year: 2020 ident: 3639_CR2 publication-title: Methods Mol Biol doi: 10.1007/978-1-0716-0377-2_1 – volume: 9 start-page: 330 issue: 2 year: 2019 ident: 3639_CR18 publication-title: Am J Cancer Res – volume: 246 start-page: 1244 issue: 11 year: 2021 ident: 3639_CR35 publication-title: Exp Biol Med (Maywood) doi: 10.1177/1535370221992703 – volume: 13 start-page: 20481 issue: 16 year: 2021 ident: 3639_CR41 publication-title: Aging (Albany NY) doi: 10.18632/aging.203430 – volume: 157 year: 2021 ident: 3639_CR4 publication-title: Environ Int doi: 10.1016/j.envint.2021.106880 – volume: 42 start-page: 491 issue: 6 year: 2011 ident: 3639_CR43 publication-title: J Mol Histol doi: 10.1007/s10735-011-9347-1 – volume: 546 year: 2022 ident: 3639_CR6 publication-title: Cancer Lett – volume: 57 start-page: 370 issue: 4 year: 2016 ident: 3639_CR36 publication-title: J Radiat Res doi: 10.1093/jrr/rrw030 – volume: 13 start-page: 1371 issue: 1 year: 2022 ident: 3639_CR20 publication-title: Nat Commun doi: 10.1038/s41467-022-29018-9 – volume: 11 start-page: 2835 issue: 9 year: 2021 ident: 3639_CR1 publication-title: Acta Pharm Sin B doi: 10.1016/j.apsb.2021.03.009 – volume: 33 start-page: 785 issue: 8 year: 2014 ident: 3639_CR40 publication-title: Hum Exp Toxicol doi: 10.1177/0960327113510537 – volume: 12 start-page: 31 issue: 1 year: 2022 ident: 3639_CR8 publication-title: Cancer Discov doi: 10.1158/2159-8290.CD-21-1059 – volume: 6 start-page: 19907 issue: 23 year: 2015 ident: 3639_CR17 publication-title: Oncotarget doi: 10.18632/oncotarget.4529 – volume: 13 start-page: 659 year: 2021 ident: 3639_CR39 publication-title: Cancer Manag Res doi: 10.2147/CMAR.S275172 – volume: 237 year: 2022 ident: 3639_CR24 publication-title: Pathol Res Pract – volume: 13 start-page: 45 issue: 1 year: 2020 ident: 3639_CR34 publication-title: Cell Mol Bioeng doi: 10.1007/s12195-019-00602-2 – volume: 10 start-page: 9489 issue: 9 year: 2017 ident: 3639_CR42 publication-title: Int J Clin Exp Pathol – volume: 294 start-page: 5261 issue: 14 year: 2019 ident: 3639_CR13 publication-title: J Biol Chem doi: 10.1074/jbc.RA118.006122 – volume: 219 year: 2021 ident: 3639_CR28 publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2020.107692 – volume: 23 start-page: 1353 issue: 3 year: 2022 ident: 3639_CR30 publication-title: Int J Mol Sci doi: 10.3390/ijms23031353 – volume: 12 start-page: S339 issue: Suppl 2 year: 2021 ident: 3639_CR5 publication-title: J Gastrointest Oncol doi: 10.21037/jgo-2019-gi-08 – volume: 12 start-page: 1847 issue: 8 year: 2022 ident: 3639_CR27 publication-title: Cancer Discov doi: 10.1158/2159-8290.CD-21-0282 – volume: 31 start-page: 991 issue: 3 year: 2011 ident: 3639_CR33 publication-title: Anticancer Res – volume: 17 start-page: 327 issue: 3 year: 2020 ident: 3639_CR11 publication-title: Curr Neurovasc Res doi: 10.2174/1567202617666200327125257 – volume: 144 start-page: 95 year: 2019 ident: 3639_CR25 publication-title: Adv Cancer Res doi: 10.1016/bs.acr.2019.05.004 – volume: 13 start-page: 11050 issue: 4 year: 2022 ident: 3639_CR12 publication-title: Bioengineered doi: 10.1080/21655979.2022.2068738 – volume: 25 start-page: 560 issue: 6 year: 2012 ident: 3639_CR23 publication-title: Dis Esophagus doi: 10.1111/j.1442-2050.2011.01279.x – volume: 1 start-page: 83 issue: 3 year: 2016 ident: 3639_CR9 publication-title: J Transl Sci doi: 10.15761/JTS.1000112 – year: 2022 ident: 3639_CR7 publication-title: Oncol Rep doi: 10.3892/or.2022.8333 – volume: 6 start-page: 6218 issue: 8 year: 2015 ident: 3639_CR14 publication-title: Oncotarget doi: 10.18632/oncotarget.3358 – volume: 13 year: 2022 ident: 3639_CR16 publication-title: Front Pharmacol – volume: 41 start-page: 771 issue: 4 year: 2009 ident: 3639_CR10 publication-title: Int J Biochem Cell Biol doi: 10.1016/j.biocel.2008.07.025 – volume: 57 start-page: 513 issue: 5 year: 2018 ident: 3639_CR22 publication-title: J Am Assoc Lab Anim Sci doi: 10.30802/AALAS-JAALAS-18-000005 – volume: 24 start-page: 65 issue: 1 year: 2019 ident: 3639_CR26 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2018.11.011 – volume: 430 start-page: 266 issue: 2 year: 2017 ident: 3639_CR29 publication-title: Dev Biol doi: 10.1016/j.ydbio.2017.07.025 – volume: 174 start-page: 4637 issue: 24 year: 2017 ident: 3639_CR38 publication-title: Br J Pharmacol doi: 10.1111/bph.13894 – volume: 40 start-page: 4486 issue: 26 year: 2021 ident: 3639_CR19 publication-title: Oncogene doi: 10.1038/s41388-021-01860-z – volume: 13 start-page: 1009 issue: 5 year: 2021 ident: 3639_CR3 publication-title: Cancers (Basel) doi: 10.3390/cancers13051009 – volume: 9 start-page: 565 issue: 7 year: 2008 ident: 3639_CR21 publication-title: Curr Drug Targets doi: 10.2174/138945008784911750 – volume: 20 start-page: 1673 issue: 9 year: 2016 ident: 3639_CR44 publication-title: J Cell Mol Med doi: 10.1111/jcmm.12862 – volume: 11 start-page: 378 issue: 4 year: 2014 ident: 3639_CR31 publication-title: Curr Neurovasc Res doi: 10.2174/1567202611666140912115107 – volume: 42 start-page: 323 issue: 1 year: 2023 ident: 3639_CR37 publication-title: Cancer Metastasis Rev doi: 10.1007/s10555-023-10087-1 – volume: 62 start-page: 142 year: 2015 ident: 3639_CR32 publication-title: Int J Biochem Cell Biol doi: 10.1016/j.biocel.2015.03.007 |
SSID | ssj0055611 |
Score | 2.3736377 |
Snippet | Objective
Wnt-induced signaling protein 1 (WISP1) and Dickkopf-1 (DKK1) are highly expressed in esophageal squamous cell carcinoma (ESCC), but no direct... Wnt-induced signaling protein 1 (WISP1) and Dickkopf-1 (DKK1) are highly expressed in esophageal squamous cell carcinoma (ESCC), but no direct connection was... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 580 |
SubjectTerms | Animals Apoptosis CCN Intercellular Signaling Proteins - genetics CCN Intercellular Signaling Proteins - metabolism CCN Intercellular Signaling Proteins - physiology Cell Line, Tumor Cell Movement Cell Plasticity - genetics Cell Proliferation Epithelial-Mesenchymal Transition - genetics Esophageal Neoplasms - genetics Esophageal Neoplasms - metabolism Esophageal Neoplasms - pathology Esophageal Squamous Cell Carcinoma - genetics Esophageal Squamous Cell Carcinoma - metabolism Esophageal Squamous Cell Carcinoma - pathology Gene Knockdown Techniques Humans Intercellular Signaling Peptides and Proteins - genetics Intercellular Signaling Peptides and Proteins - metabolism Intercellular Signaling Peptides and Proteins - physiology Male Medicine Medicine & Public Health Mice Mice, Nude Neoplastic Stem Cells - pathology Oncology Phenotype Proto-Oncogene Proteins - genetics Proto-Oncogene Proteins - metabolism Proto-Oncogene Proteins - physiology Research Article |
Title | Knockdown of WISP1/DKK1 restrains phenotypic plasticity in esophageal squamous cell carcinoma by suppressing epithelial–mesenchymal transition and stemness |
URI | https://link.springer.com/article/10.1007/s12094-024-03639-6 https://www.ncbi.nlm.nih.gov/pubmed/39093516 https://www.proquest.com/docview/3087356291 |
Volume | 27 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB7RrYS48H4sj5WRuEFK7DiJfdxCl8KqFRJdUU6R4zhQwXoDyR6WE_-BM3-OX8JMHlRQhNR7bCfj8cznzDczAI8iimVqVwZSChmgh-KBVrIIRBFGpnDaOk35zgeHyf5CvjqOj_uksHpguw8hydZSnya7iZDK2OKUFHzUQbIF2zFXWo1ge_ri3XxvsMDU8ZH3CTL_HvmnEzqDLM9ERVtnM7sCi-E1O47Jx511k-_Yr39VcDzvd1yFyz36ZNNOXa7BBeevw8WDPr5-A37MPdrHAm_mbFWyty_fvOZPn8_nnFEHD2omUTPihK2aTXViWYXIm0jZzYadeOaoIQJaJ5y__rw29EuBUViAWWpX5FdLw_INq9dVR73175mrKCHkE56An9--LykNyn7YLHF8Qw605ZIx4wtGtabJIt-Eo9ne0bP9oG_gEFihVRPwWBXWJiZ1KcIaJ22onEgKxDi6TEyeRqWNXYkXJiVMrkPpDKIjKUoemzwUNroFI7_y7g4wx11ccuVSLYw0eGUMRZlKrQRRJOM4GsPjYUOzqivTkZ0WZCaBZyjwrBV4lozh4bDnGZ4mkoXxDsWSUX3ECCGh5mO43SnD7_kiTUFjjqOfDBub9Qe-_s9id8_3-D24JKjFcEsMvw-j5svaPUDc0-QTVPPZ7u7hpFf3CWwtxPQXkE3_Zw |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZokaAXVMqjC5QaqbcSETvOw8eKttqy3QqpW7U3y3EmsBLrDSR72Bv_gTN_jl_CTDZpVRUh9R47kj9n5pvM42NsL6JcpoYyUEqqAD2UCHSmikAWYWQL0A409TuPz5Lhhfp0FV91TWF1X-3epyRbS33T7CZDGmOLW1LyUQfJGnuIZCAj3YILedDbX9J7FF17zL_X3XZBd3jlnZxo62qON9mTjiPygxWoT9kD8Fvs0bjLgj9jv0cerViB8TOfl_zy5Pyz-HA4GglOOhsk-VBzqtyaN8tq6niF_JhKp5sln3oOJFuANgT3r78vLAX-nH7ec0eiQn4-szxf8npRrQpk_RcOFbVtfMN7-ufnrxk1K7mvyxmub8jNtRVf3PqC00RospvP2eT4aPJxGHQyC4GTOmsCEWeFc4lNIUXyAcqFGcikQCaiy8TmaVS6GEoMazJpcx0qsMhhlCxFbPNQuugFW_dzD9uMg4C4FBmkWlplMbALZZkqnUkqZIzjaMD2-4M31WqYhrkZm0wwGYTJtDCZZMDe9dgYvPN0FtYDHouhKYYREjctBuzlCrTr_SJNqV2Bq9_3KJrus6z_87JX93t8lz0eTsan5vTkbPSabUgSBW5Lud-w9ebHAnaQqTT52_Zi_gUD1OLm |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZKK1VcEJRHl1eNxA2ijR3n4WNFWbVdWlWiFb1ZjjNuK7HewGYPe-M_cObP8UuYyYNSFSFxjx3J32Tmc-abGcZeJ5TL1OAjpaSKMEKJSBeqimQVJ7YC7UBTvfPRcbZ_pg7P0_M_qvhbtfuQkuxqGqhLU2jGdeXH14VvMqaWtrg9JSJ1lN1hG-iOBVn6mdwdfDHNfhR9qczf190MR7c45q38aBt2JvfZvZ4v8t0O4AdsDcIW2zzqM-IP2Y9pQI9W4V2azz3_dPDxRIz3plPBaeYGjX9YcFJxzZtVfeV4jVyZZNTNil8FDjTCAP0J7r_4srT0E4DTj3zuaMBQmM8sL1d8saw7sWy44FBTCcdntNmf377PqHDJXa5muL6hkNeqv7gNFafu0ORDH7HTyfvTd_tRP3IhclIXTSTSonIusznkSERAubgAmVXISrTPbJkn3qXg8YpTSFvqWIFFPqOkF6ktY-mSx2w9zANsMw4CUi8KyLW0yuIlL5Y-V7qQJGpM02TE3gwHb-qusYa5bqFMMBmEybQwmWzEXg3YGLR_OgsbAI_FUEfDBEmcFiP2pAPt936JpjSvwNVvBxRN_4ku_vGyp__3-A7bPNmbmA8Hx9Nn7K6k-cCtqvs5W2--LuEFkpamfNna5S_n3eci |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Knockdown+of+WISP1%2FDKK1+restrains+phenotypic+plasticity+in+esophageal+squamous+cell+carcinoma+by+suppressing+epithelial-mesenchymal+transition+and+stemness&rft.jtitle=Clinical+%26+translational+oncology&rft.au=Fu%2C+C&rft.au=Lu%2C+Z&rft.au=Shi%2C+J&rft.au=Liu%2C+F&rft.date=2025-02-01&rft.eissn=1699-3055&rft.volume=27&rft.issue=2&rft.spage=580&rft_id=info:doi/10.1007%2Fs12094-024-03639-6&rft_id=info%3Apmid%2F39093516&rft.externalDocID=39093516 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1699-3055&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1699-3055&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1699-3055&client=summon |